维普期刊资源整合服务平台（V6.5）

79篇 您的检索式：作者名="Ruzzo A"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Pharma- cogenetic profiling' in patients with advanced color- ectal cancer treated with first-line FOLFOX-4 chem- otherapy显示文摘	Ruzzo A Graziano F Loupakis F	2007	J ClinOncol2007，25，10：	1
2	Pharmacogenetic profiling for cetuximab plus irinotecan therapy in patients with refractory advanced colorectal cancer显示文摘	Graziano F Ruzzo A Loupakis F	2008	J Clin Oncol2008，26，9：	1
3	High let -7a microRNA levels in KRAS - mutated colorectal carcinomas may rescue anti - EGFR ther- apy effects in patients with chemotherapy - refractory metastatic disease 显示文摘	Ruzzo A Graziano F Vincenzi B	2012	Oneologist2012，17，6：	1
4	Molecular predictors of efficacy to anti-EGFR agents in colorectal cancer patients显示文摘	Ruzzo A Graziano F Canestrari E	2010	Curr Cancer Drug Targets2010，10，1：	1
5	Polymorphisms in genes involved in DNA repair and metabolism of xenobiotics in individual susceptibility to sporadic diffuse gastric cancer显示文摘	Ruzzo A Canestrari E Maltese P	2007	Clin Chem Lab Med2007，45，7：	1
6	6S RNA is a widespread regulator of eabacterial RNA polymerase that resembles an open promoter显示文摘	Barrick J E Sudarzan N Ruzzo W A	2005	RNA2005，11，：	1
7	Pharmacogenetic profiling and clinical outcome of patients with advanced gastric cancer treated with palliative chemotherapy 显示文摘	Ruzzo A Graziano F Kawakami K	2006	J Clin Oncol2006，24，12：	1
8	Protection in op-erating systems显示文摘	HARRISON M A RUZZO W L ULLMAN J D	1976	Communications of the ACM1976，19，8：	1
9	KRAS codon61,146 and BRAF mutations predict resistance to cetu-ximab plus irinotecan in KRAS codon 12 and 13 wild-typemetastatic colorectal cancer显示文摘	Loupakis F Ruzzo A Cremolini C	2009	Br J Cancer2009，101，4：	1
10	Protection in operating systems显示文摘	HARRISON M A RUZZO W L ULLMAN J D	1976	Communications of the ACM1976，19，8：	1
11	Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFOX-4 chemotherapy显示文摘	Ruzzo A Graziano F Loupakis F	2007	J Clin Oncol2007，25，10：	1
12	Protection in operating systems显示文摘	Ruzzo M L Ullman J D	1976	Communication of the ACM1976，8，：	1
13	Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFOX-4 chemotherapy显示文摘	Ruzzo A Graziano F Loupakis F	2007	Clin Oncol2007，25，10：	1
14	Pharmacogenetic profiling in patients with advanced colorectal cancer treated with firstline FOLFOX-4 chemotherapy 显示文摘	Ruzzo A Graziano F Loupakis F	2007	J Clin Oncol2007，25，10：	1
15	Prognostic analysis of E-cadherin gene promoter hypermethylation in patients with surgically resected,node-positive,diffuse gastric cancer显示文摘	Graziano F Arduini F Ruzzo A	2004	Clin Cancer Res2004，10，8：	1
16	Pharmacogenetic profiling and clinical outcome of patients with advanced gastric cancer treated with palliative chemotherapy显示文摘	Ruzzo A Graziano F Kawakami K	2006	J Clin Oncol2006，24，：	1
17	Protection in operating systems显示文摘	Harrison M A Ruzzo W L Ullman J D	1976	Communications of the ACM (CACM)1976，19，8：	1
18	Prognostic analysis of E-cadherin gene promoter hypermethylation in patients with surgically resected,node-positive,diffuse gastric cancer显示文摘	Graziano F Arduini F Ruzzo A	2004	Clin Cancer Res2004，10，8：	1
19	Pharmacogenetic profiling and clinical outcome of patients with advanced gastric cancer treated with palliative chemotherapy显示文摘	Ruzzo A Graziano F Kawakami K	2006	J Clin Oncol2006，24，12：	1
20	Interleukin 1B gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in Helicobacter pylori-negative gastric cancer of intestinal and diffuse histotype 显示文摘	Ruzzo A Graziano F Pizzagalli F	2005	Ann Oncol2005，16，6：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示